JNJ-28330835

From Wikipedia, the free encyclopedia

Other namesJNJ28330835
Legal status
  • US: Investigational drug
JNJ-28330835
Clinical data
Other namesJNJ28330835
Drug classSelective androgen receptor modulator
Legal status
Legal status
  • US: Investigational drug
Identifiers
  • (S)-N-(4-cyano-3-(trifluoromethyl)phenyl)-5-methyl-3-(trifluoromethyl)-4,5-dihydro-1H-pyrazole-5-carboxamide
CAS Number
PubChem CID
DrugBank
ChemSpider
UNII
ChEMBL
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC14H10F6N4O
Molar mass364.251 g·mol−1
3D model (JSmol)
  • O=C([C@@]1(C)NN=C(C(F)(F)F)C1)NC2=CC=C(C#N)C(C(F)(F)F)=C2
  • InChI=1S/C14H10F6N4O/c1-12(5-10(23-24-12)14(18,19)20)11(25)22-8-3-2-7(6-21)9(4-8)13(15,16)17/h2-4,24H,5H2,1H3,(H,22,25)/t12-/m0/s1
  • Key:RYBKPGYFXRNMMU-LBPRGKRZSA-N

JNJ-28330835 is a drug which acts as a selective androgen receptor modulator (SARM).[1] In studies on rats it was found to enhance muscle growth and sexual behavior but with minimal effects on prostate gland size. A number of related compounds are known, though JNJ-28330835 has progressed furthest through development.[2][3] The drug is a potential designer drug, though it has not yet been encountered as of 2020.[4]

References

Related Articles

Wikiwand AI